bioProtonics, LLC
SANTA BARBARA, CA · Founded 2018 · CIK 0001759133 · Medtech · Private
Magnetic Resonance Histopathology (MRH) technology for non-invasive tissue analysis during MRI scans
bioprotonics.com →- Grants
- $150K
- 1 award
- Sector median: 1
- Raised
- $6.4M
- 10 Form D · Jul 2025
- 15 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 11
- 6 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Development of a novel, high-sensitivity diagnostic for bone disease, enabling early-stage diagnosis and precise monitoring of therapy effects. | $150,000 | |
| Private capital raised | Form D · SEC | $781,987 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $176,952 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $594,527 | |
| Private capital raised | Form D · SEC | $576,952 | |
| Private capital raised | Form D · SEC | $1,048,785 | |
| Private capital raised | Form D · SEC | $203,126 | |
| Private capital raised | Form D · SEC | $108,900 | |
| Private capital raised | Form D · SEC | $74,415 | |
| Private capital raised | Form D · SEC | $2,701,248 | |
| Private capital raised | Form D · SEC | $150,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 994 | iotaMotion, Inc. | — | $20M |
| 995 | DASISIMULATIONS LLC | — | $1.8M |
| 996 | QUARKSEN LLC | — | — |
| 997 | bioProtonics, LLC | — | $6.4M |
| 998 | Vibrant Composites Inc. | — | $1.4M |
| 999 | PLx Pharma Inc. | — | $64M |
| 1000 | MULTIVARIATE SYSTEMS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Scott CannizzaroDirector · Executive Officer
- Chris CorpuzExecutive Officer
- Daniel DoioronDirector · Executive Officer
- Daniel DoironDirector · Executive Officer
- DANIEL DOIRONDirector · Executive Officer
- Forrest FlemingDirector · Executive Officer
- Timothy JamesDirector · Executive Officer
- W. JamesDirector · Executive Officer
- TIMOTHY JAMESDirector
- Kristin LoomisDirector · Executive Officer
- KRISTIN LOOMISDirector
- Ryan ShieldsDirector
- A. TripathiDirector · Executive Officer
- Charles WincklerExecutive Officer
Patents
- Selective Sampling For Assessing Structural Spatial Frequencies With Specific Contrast Mechanismsgranted
- Method To Measure Tissue Texture Using Nmr Spectroscopy To Identify The Chemical Species Of Component Textural Elements In A Targeted Region Of Tissuegranted
- Selective Sampling For Assessing Structural Spatial Frequencies With Specific Contrast Mechanismsgranted
- Selective Sampling For Assessing Structural Spatial Frequencies With Specific Contrast Mechanismsgranted
- Method For Assessing Structural Spatial Frequencies Using Hybrid Sampling With Non-zero Gradient For Enhancement Of Selective Samplinggranted
- Selective Sampling Magnetic Resonance-based Method For Assessing Structural Spatial Frequenciesgranted
- Selective Sampling Magnetic Resonance-based Method For Assessing Structural Spatial Prequenciesapplication
- Selective Sampling For Assessing Structural Spatial Frequencies With Specific Contrast Mechanismsapplication
- Magnetic Resonance-based Technique For High Resolution Measurement Of Tissue Textureapplication
- Selective Sampling For Assessing Structural Spatial Frequencies With Specific Contrast Mechanismsapplication
- Magnetic-resonance-based Method For Measuring Microscopic Histologic Soft Tissue Texturesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.